articleHealth and Quality of Life OutcomesJan 1, 2004GOLD OA

Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease.

Pfizer (United States) · IQVIA (United Kingdom) · +3 more institutions

PubMed
Indexed incrossrefdoajpubmed

Abstract

Background

The objective of this study was to develop and psychometrically evaluate a general measure of patients' satisfaction with medication, the Treatment Satisfaction Questionnaire for Medication (TSQM).

Methods

The content and format of 55 initial questions were based on a formal conceptual framework, an extensive literature review, and the input from three patient focus groups. Patient interviews were used to select the most relevant questions for further evaluation (n = 31). The psychometric performance of items and resulting TSQM scales were examined using eight diverse patient groups (arthritis, asthma, major depression, type I diabetes, high cholesterol, hypertension, migraine, and psoriasis) recruited from a national longitudinal panel study of chronic illness (n = 567). Participants were then randomized to complete the test items using one of two alternate scaling methods (Visual Analogue vs. Likert-type).

Citation impact

992
total citations
FWCI
7.31
Percentile
100%
References
90
Citations per year

Authors

7

Topics & keywords

Keywords
  • Cronbach's alpha
  • Varimax rotation
  • Medicine
  • Visual analogue scale
  • Clinical psychology
  • Physical therapy
  • Psychometrics
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding